Afferent (acquired by Merck)

Alios (acquired by Johnson+Johnson)

Ambit (acquired by Daiichi Sankyo)

Ambrx (acquired by Wuxi)

Artus (acquired by Qiagen)

Avexis (acquired by Novartis)

BioFire (acquired by bioMérieux)

BioXell (acquired by Cosmo)

Care Innovations (acquired by PRA Health Sciences)

CGI (acquired by Gilead)

DVS (acquired by Fluidigm)

Envoy (acquired by Takeda)

Flatiron (acquired by Roche)

Foundation Medicine (acquired by Roche)

HistoRx (acquired by Genoptix)

Leukosite (acquired by Millennium)

LTI (acquired by Bial)

Memory (acquired by Roche)

Miikana (acquired by EntreMed)

MySugr (acquired by Roche)

Pandion (acquired by Merck)

Sequana (acquired by Celera)

Stratos Genomics (acquired by Roche)

Syrrx (acquired by Takeda)

Tripath (acquired by Becton Dickinson)

Viewics (acquired by Roche)

Zikanii (acquired by Eloxx)

Addex

Aileron

Anadys

Black Diamond Therapeutics

C4 Therapeutics

Caliper

Complete Genomics

Conatus

Curetis

CV Therapeutics

CytomX

deCode

Fibrogen, Inc

Halozyme Therapeutics

Horizon Discovery

Miragen

Pharmasset

Protein Design Labs, Inc

Senseonics

Taimed

TiGenix

Xenon